Publication | Open Access
CAT-8015: A Second-Generation<i>Pseudomonas</i>Exotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies
103
Citations
14
References
2009
Year
CAT-8015 is a CD22-targeting immunotoxin that, in preclinical studies, has greatly improved efficacy compared with CAT-3888.
| Year | Citations | |
|---|---|---|
Page 1
Page 1